Condition: Rheumatoid Arthritis
Interventions : Drug: 50 mg LX3305 QD; Drug: 100 mg LX3305 QD; Drug: 150 mg LX3305 QD; Drug: 200 mg LX3305 QD; Drug: 250 mg LX3305 QD; Drug: 300 mg LX3305 QD; Drug: 400 mg LX3305 QD; Drug: 250 mg LX3305 BID; Drug: 500 mg LX3305 QD; Drug: Placebo
Sponsor: Lexicon Pharmaceuticals
Not yet recruiting - verified August 2011
